51718-80-0 Usage
Description
METHYL 2-(1H-IMIDAZOL-4-YL)ACETATE HYDROCHLORIDE is a chemical compound belonging to the imidazole family, characterized by its unique structure and properties. It is a potent non-thiol inhibitor of farnesyl protein transferase, which plays a significant role in various cellular processes.
Uses
Used in Pharmaceutical Industry:
METHYL 2-(1H-IMIDAZOL-4-YL)ACETATE HYDROCHLORIDE is used as a research compound for the development of potential therapeutic agents targeting farnesyl protein transferase. Its ability to inhibit this enzyme makes it a valuable tool in the study and treatment of various diseases associated with the enzyme's dysregulation.
Used in Analytical Chemistry:
METHYL 2-(1H-IMIDAZOL-4-YL)ACETATE HYDROCHLORIDE is used as an analytical reagent in the identification and quantification of farnesyl protein transferase inhibitors. Its specificity for the enzyme allows researchers to better understand the interactions between the compound and the enzyme, which can lead to the development of more effective drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 51718-80-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,7,1 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 51718-80:
(7*5)+(6*1)+(5*7)+(4*1)+(3*8)+(2*8)+(1*0)=120
120 % 10 = 0
So 51718-80-0 is a valid CAS Registry Number.
51718-80-0Relevant articles and documents
Esters of 4 hydroxymethylimidazole and 4 imidazoleacetic acid
Schunack
, p. 46 - 51,48,50 (1974)
-
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES AS GLUTAMINASE INHIBITORS FOR TREATING CANCERS THEREOF
-
Page/Page column 186, (2014/06/11)
Provided are compounds of formula (I), wherein X, Y, Z, W, m, n, o, p, R1, R2 and R6 are defined as in the description. Pharmaceutical compositions and uses as glutaminase inhibitors for treating cancers thereof are also provided.
IMIDAZOLE DERIVATIVES USED AS TAFIA INHIBITORS
-
, (2008/06/13)
The present invention relates to compounds of formula (I) which are inhibitors of the activated thrombin-activatable fibrinolysis inhibitor. The compounds of formula (I) are suited for producing medicaments for the prevention and treatment of diseases acc